Estimated Savings Using Patient Assistance Programs on Drugs for Chronic Conditions

Estimated maximum savings is based on the average cash price for a 30-day supply of each drug. This is a sample of five drugs that have patient assistance programs (PAPs). The estimated savings assumes that the PAP covers the full price of the drug; limitations may be based on PAP requirements.
GoodRx (yellow logo)